A. Naylor

577 total citations
17 papers, 495 citations indexed

About

A. Naylor is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, A. Naylor has authored 17 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 9 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in A. Naylor's work include Synthesis of β-Lactam Compounds (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Synthesis and Catalytic Reactions (2 papers). A. Naylor is often cited by papers focused on Synthesis of β-Lactam Compounds (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Synthesis and Catalytic Reactions (2 papers). A. Naylor collaborates with scholars based in United Kingdom and United States. A. Naylor's co-authors include Andrew K. Takle, Alessandra Gaiba, Robert W. Ward, Vincent Bordas, David G. Smith, Jason Witherington, Brian P. Slingsby, Frank D. King, David K. Dean and David M. Wilson and has published in prestigious journals such as Tetrahedron, Bioorganic & Medicinal Chemistry Letters and The Journal of Antibiotics.

In The Last Decade

A. Naylor

16 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Naylor United Kingdom 11 327 174 54 53 34 17 495
Alan J. Foubister United Kingdom 14 314 1.0× 220 1.3× 49 0.9× 55 1.0× 26 0.8× 33 522
Shuji Kitamura Japan 12 204 0.6× 276 1.6× 34 0.6× 23 0.4× 26 0.8× 14 476
Charles Q. Meng Canada 10 255 0.8× 141 0.8× 21 0.4× 67 1.3× 29 0.9× 16 482
Sarah C. Traeger United States 13 224 0.7× 149 0.9× 22 0.4× 71 1.3× 33 1.0× 26 464
Shubhangi S. Soman India 16 373 1.1× 122 0.7× 49 0.9× 86 1.6× 63 1.9× 54 561
Salah A. Abdel‐Aziz Egypt 14 440 1.3× 269 1.5× 51 0.9× 77 1.5× 86 2.5× 35 653
Mohamed A.H. Ismail Egypt 12 278 0.9× 154 0.9× 56 1.0× 27 0.5× 20 0.6× 28 422
S. Kesten United States 8 187 0.6× 133 0.8× 31 0.6× 114 2.2× 22 0.6× 13 361
Simon Peace United Kingdom 14 440 1.3× 208 1.2× 63 1.2× 28 0.5× 54 1.6× 22 647
Smriti Khanna India 11 151 0.5× 172 1.0× 41 0.8× 46 0.9× 20 0.6× 19 348

Countries citing papers authored by A. Naylor

Since Specialization
Citations

This map shows the geographic impact of A. Naylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Naylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Naylor more than expected).

Fields of papers citing papers by A. Naylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Naylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Naylor. The network helps show where A. Naylor may publish in the future.

Co-authorship network of co-authors of A. Naylor

This figure shows the co-authorship network connecting the top 25 collaborators of A. Naylor. A scholar is included among the top collaborators of A. Naylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Naylor. A. Naylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bamford, Mark J., Emmanuel H. Demont, Richard L. Elliott, et al.. (2009). Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs). Bioorganic & Medicinal Chemistry Letters. 19(13). 3602–3606. 12 indexed citations
2.
Panchal, Terry, Mark J. Bamford, Emmanuel H. Demont, et al.. (2009). Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs). Bioorganic & Medicinal Chemistry Letters. 19(23). 6813–6817. 10 indexed citations
3.
Takle, Andrew K., Mark J. Bamford, Susannah Davies, et al.. (2008). The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 18(15). 4373–4376. 20 indexed citations
4.
Witherington, Jason, Vincent Bordas, Richard L. Elliott, et al.. (2006). Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 16(21). 5538–5541. 6 indexed citations
5.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2006). Pyridone derivatives as potent and selective VLA-4 integrin antagonists. Bioorganic & Medicinal Chemistry Letters. 16(8). 2256–2259. 12 indexed citations
6.
Takle, Andrew K., Murray J. B. Brown, Susannah Davies, et al.. (2005). The identification of potent and selective imidazole-based inhibitors of B-Raf kinase. Bioorganic & Medicinal Chemistry Letters. 16(2). 378–381. 170 indexed citations
7.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2003). 6-Aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 13(18). 3055–3057. 103 indexed citations
8.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2003). 6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 13(18). 3059–3062. 73 indexed citations
9.
Witherington, Jason, Vincent Bordas, Alessandra Gaiba, et al.. (2003). 6‐Aryl‐pyrazolo[3,4‐b]pyridines: Potent Inhibitors of Glycogen Synthase Kinase‐3 (GSK‐3).. ChemInform. 34(51). 5 indexed citations
10.
Branch, Clive L., George Burton, Steven Coulton, et al.. (1998). Novel C-2 Substituted Carbapenem Derivatives. Part IV. Synthesis and Biological Activity of Five Membered Heteroaromatic Derivatives.. The Journal of Antibiotics. 51(2). 210–220. 6 indexed citations
13.
Burton, George, et al.. (1996). Novel C-2 Substituted Carbapenem Derivatives. Part I. Synthesis and Biological Activity of Non-aromatic Heterocyclic Derivatives.. The Journal of Antibiotics. 49(12). 1258–1265. 5 indexed citations
14.
Davies, John, et al.. (1995). Aryl participation in methanolysis of N-chloro-1,4-dihydro-1,4-iminonaphthalenes (7-azabenzonorbornadienes) and derivatives. Tetrahedron. 51(31). 8655–8664. 3 indexed citations
15.
Naylor, A., Nicola M. Howarth, & John R. Malpass. (1993). Synthetic approaches to nortropanes and nortrop-6-enes; intramolecular displacement by nitrogen in 7-membered rings. Tetrahedron. 49(2). 451–468. 23 indexed citations
16.
Davies, John, et al.. (1992). 15N nuclear magnetic resonance studies of azabicycles; unusual deshielding of nitrogen in the 7-azabicyclo[2.2.1]heptyl ring system. Tetrahedron. 48(46). 10161–10176. 13 indexed citations
17.
Weibert, Robert T., Raymond J. Townsend, David G. Kaiser, & A. Naylor. (1983). Lack of ibuprofen secretion into human milk.. PubMed. 1(5). 457–8. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026